Corporate News     17-Aug-22
Natco Pharma receives USFDA tentative approval for Trabectedin for Injection
Natco Pharma announced that the U.S. Food and Drug Administration has granted tentative approval to its Abbreviated New Drug Application (ANDA) for Trabectedin for Injection (generic for Yondelis® ) for the 1mg/vial presentation.

According to industry sales data, Yondelis® generated annual sales of $49.7 million for the twelve months ending June 2022 in the US market.

Previous News
  Natco Pharma consolidated net profit rises 549.65% in the September 2023 quarter
 ( Results - Announcements 14-Nov-23   17:36 )
  Natco Pharma consolidated net profit rises 59.05% in the June 2024 quarter
 ( Results - Announcements 12-Aug-24   15:07 )
  Natco Pharma
 ( Results - Analysis 15-Feb-24   10:36 )
  Sensex, Nifty end lower amid global cues; PSU bank shares slides; VIX rallies 3.86%
 ( Market Commentary - Quick Review 04-Sep-24   15:51 )
  Natco Pharma consolidated net profit rises 327.20% in the June 2022 quarter
 ( Results - Announcements 09-Aug-22   15:33 )
  Natco Pharma Ltd soars 0.97%, up for fifth straight session
 ( Hot Pursuit - 26-Jul-24   13:00 )
  Natco Pharma Ltd leads gainers in 'A' group
 ( Hot Pursuit - 06-Mar-24   12:00 )
  Natco Pharma to hold board meeting
 ( Corporate News - 09-May-24   16:50 )
  Natco Pharma launches additional strengths of Revlimid generic in US
 ( Hot Pursuit - 10-Mar-23   08:47 )
  Board of Natco Pharma approves buyback of shares up to Rs 700 cr
 ( Corporate News - 08-Mar-23   11:50 )
  Board of Natco Pharma recommends Second Interim Dividend
 ( Corporate News - 16-Nov-23   09:39 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top